Pfizer seeks authorization for its vaccine for 5-11 year olds

In recent months, the World Health Organization (WHO) has nevertheless insisted that the urgency is to vaccinate the population of poor countries before children and adolescents in rich countries. The Pfizer / BioNTech alliance submitted an authorization request to Health Canada on Monday October 18 for the use of its coronavirus vaccine in children aged 5 to 11, said pharmaceutical companies and the Canadian government.

“This is the first request that Health Canada has received for the use of a vaccine against Covid-19 in this age group, “the Ministry of Health said in a press release. The authorization request is based on data of trials carried out on 2,268 children of this age group for whom the dosage was lowered to 10 micrograms per injection (three times less than the standard dose), which is, according to the company, “the preferable dose” for 5 to 11 year olds.

This same Pfizer / BioNTech vaccine is approved at Canada for ages 12 and over. Health Canada assures that it will only authorize the use of the vaccine “if the independent and thorough scientific review of all the data submitted confirms that the benefits of the vaccine outweigh the risks“with this group. The Canadian ministry also indicated that” other manufacturers are also testing their vaccines on children of different age groups. “

Earlier this month, the laboratories Pfizer and BioNTech made the same request for 5-11 year olds in the United States. Childhood immunizations raise questions around the world. Many countries vaccinate adolescents from the age of 12, but very few do so below that age.

The editorial staff recommends you


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.